Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL604339 | 0.88 | — | — | |
| SCHEMBL21467045 | 0.88 | CHRM5 (0.39) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL169425 | 0.88 | — | — | |
| SCHEMBL497934 | 0.85 | — | — | |
| SCHEMBL14193884 | 0.79 | — | — | |
| SCHEMBL602116 | 0.78 | — | — | |
| SCHEMBL2283214 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL10282692 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL22790683 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL19219867 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7081092-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL COMPANY (US) | 2006-07-25 | — | — | US | claimed |
| US-20050049484-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2005-03-03 | — | — | US | claimed |
| US-6802813-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL CO. | 2004-10-12 | — | — | US | claimed |
| US-20030220563-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2003-11-27 | — | — | US | claimed |
| US-20020065467-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | SCHUTT ERNEST G (US) | 2002-05-30 | — | — | US | claimed |
| WO-1998053855-A1 | METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-03 | — | — | WO | claimed |
| US-9554993-B2 | Pulmonary delivery particles comprising an active agent | NOVARTIS AG (CH) | 2017-01-31 | — | — | US | disclosed |
| US-8168223-B1 | Engineered particles and methods of use | NOVARTIS PHARMA AG (CH) | 2012-05-01 | — | — | US | disclosed |
| US-20100272823-A1 | PULMONARY DELIVERY PARTICLES COMPRISING WATER INSOLUBLE OR CRYSTALLINE ACTIVE AGENTS | NOVARTIS PHARMA AG (CH) | 2010-10-28 | — | — | US | disclosed |
| EP-1019022-B2 | METHOD FOR FORMING A POWDER COMPRISING PERFORATED MICROPARTICLES | NOVARTIS AG (CH) | 2010-07-28 | — | — | EP | disclosed |
| US-20080233194-A1 | Dispersion for pulmonary delivery of a bioactive agent | NEKTAR THERAPEUTICS (US) | 2008-09-25 | — | — | US | disclosed |
| US-7393544-B2 | Dispersion for pulmonary delivery of a bioactive agent | NEKTAR THERAPEUTICS (US) | 2008-07-01 | — | — | US | disclosed |
| US-7306787-B2 | Engineered particles and methods of use | NEKTAR THERAPEUTICS (US) | 2007-12-11 | — | — | US | disclosed |
| US-20020188281-A1 | Stabilized bioactive preparations and method of use | NOVARTIS PHARMA AG (CH) | 2002-12-12 | — | — | US | disclosed |
| US-6433040-B1 | ADMINISTERING NONAQUEOUS SUSPENSION IN LIQUID FLUOROCHEMICAL WITH PLURALITY OF PERFORATED MICROSTRUCTURES FILLED WITH BIOACTIVE AGENT DISPERSED THERIN TO NOSE OR LUNGS; DRUG DELIVERY | INHALE THERAPEUTIC SYSTEMS, INC. | 2002-08-13 | — | — | US | disclosed |
| US-20020065467-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | SCHUTT ERNEST G (US) | 2002-05-30 | — | — | US | disclosed |
| EP-1019020-A1 | STABILIZED BIOACTIVE PREPARATIONS AND METHODS OF USE | Inhale Therapeutic Systems, Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999016420-A9 | STABILIZED PREPARATIONS FOR USE IN NEBULIZERS | ALLIANCE PHARMA (US) | 1999-06-17 | — | — | WO | disclosed |
| WO-1999016421-A1 | STABILIZED BIOACTIVE PREPARATIONS AND METHODS OF USE | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1998053855-A1 | METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-03 | — | — | WO | disclosed |